Tech Company Financing Transactions
Allozymes Funding Round
Allozymes, based in Singapore, raised $15 million from Entrepreneur First, ID Fund and Seventure Partners.
Transaction Overview
Company Name
Announced On
5/3/2024
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
79 Science Park Drive 06-05
Singapore, 118264
Singapore
Singapore, 118264
Singapore
Phone
Undisclosed
Website
Email Address
Overview
Allozymes applies its proprietary platform technology to rapidly develop novel enzymes, revolutionizing the way that industries manufacture complex natural products. At Allozymes, we believe there is a better way. Our goal is to replace traditional manufacturing methods with cleaner, greener, scalable methods, by unlocking the power of custom designed enzymes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peyman Salehian
Chief Technical Officer
Akbar Vahidi
VP - Bus. Development
Deepak Raghothaman
Browse more venture capital transactions:
Prev: 5/3/2024: Latus Bio venture capital transaction
Next: 5/3/2024: umgrauemeio venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs